163 related articles for article (PubMed ID: 37550350)
1. Effects of metformin and donepezil on the prevention of doxorubicin-induced cardiotoxicity in breast cancer: a randomized controlled trial.
Osataphan N; Phrommintikul A; Leemasawat K; Somwangprasert A; Apaijai N; Suksai S; Sirikul W; Gunaparn S; Chattipakorn SC; Chattipakorn N
Sci Rep; 2023 Aug; 13(1):12759. PubMed ID: 37550350
[TBL] [Abstract][Full Text] [Related]
2. Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial.
Čiburienė E; Aidietienė S; Ščerbickaitė G; Sadauskienė E; Sudavičienė D; Baltruškevičienė E; Brasiūnienė B; Drobnienė M; Čelutkienė J
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138243
[No Abstract] [Full Text] [Related]
3. Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer: A Randomized Clinical Trial.
Boekhout AH; Gietema JA; Milojkovic Kerklaan B; van Werkhoven ED; Altena R; Honkoop A; Los M; Smit WM; Nieboer P; Smorenburg CH; Mandigers CM; van der Wouw AJ; Kessels L; van der Velden AW; Ottevanger PB; Smilde T; de Boer J; van Veldhuisen DJ; Kema IP; de Vries EG; Schellens JH
JAMA Oncol; 2016 Aug; 2(8):1030-7. PubMed ID: 27348762
[TBL] [Abstract][Full Text] [Related]
4. Prevention of doxorubicin-induced Cardiotoxicity by pharmacological non-hypoxic myocardial preconditioning based on Docosahexaenoic Acid (DHA) and carvedilol direct antioxidant effects: study protocol for a pilot, randomized, double-blind, controlled trial (CarDHA trial).
Carrasco R; Ramirez MC; Nes K; Schuster A; Aguayo R; Morales M; Ramos C; Hasson D; Sotomayor CG; Henriquez P; Cortés I; Erazo M; Salas C; Gormaz JG
Trials; 2020 Feb; 21(1):137. PubMed ID: 32019575
[TBL] [Abstract][Full Text] [Related]
5. Use of N-terminal pro-brain natriuretic peptide to assess left ventricular function after adjuvant doxorubicin therapy in early breast cancer patients: a prospective series.
Cil T; Kaplan AM; Altintas A; Akin AM; Alan S; Isikdogan A
Clin Drug Investig; 2009; 29(2):131-7. PubMed ID: 19133708
[TBL] [Abstract][Full Text] [Related]
6. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics.
Arinno A; Maneechote C; Khuanjing T; Ongnok B; Prathumsap N; Chunchai T; Arunsak B; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Biochem Pharmacol; 2021 Oct; 192():114743. PubMed ID: 34453902
[TBL] [Abstract][Full Text] [Related]
8. Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50 years.
Jacobse JN; Steggink LC; Sonke GS; Schaapveld M; Hummel YM; Steenbruggen TG; Lefrandt JD; Nuver J; Crijns APG; Aleman BMP; van der Meer P; Gietema JA; van Leeuwen FE
Eur J Heart Fail; 2020 Feb; 22(2):338-346. PubMed ID: 31696625
[TBL] [Abstract][Full Text] [Related]
9. Role of Troponins I and T and N-Terminal Prohormone of Brain Natriuretic Peptide in Monitoring Cardiac Safety of Patients With Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Trastuzumab: A Herceptin Adjuvant Study Cardiac Marker Substudy.
Zardavas D; Suter TM; Van Veldhuisen DJ; Steinseifer J; Noe J; Lauer S; Al-Sakaff N; Piccart-Gebhart MJ; de Azambuja E
J Clin Oncol; 2017 Mar; 35(8):878-884. PubMed ID: 28199174
[TBL] [Abstract][Full Text] [Related]
10. Global left ventricular longitudinal strain is closely associated with increased neurohormonal activation after acute myocardial infarction in patients with both reduced and preserved ejection fraction: a two-dimensional speckle tracking study.
Ersbøll M; Valeur N; Mogensen UM; Andersen M; Greibe R; Møller JE; Hassager C; Søgaard P; Køber L
Eur J Heart Fail; 2012 Oct; 14(10):1121-9. PubMed ID: 22753861
[TBL] [Abstract][Full Text] [Related]
11. Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients.
Yu LR; Cao Z; Makhoul I; Daniels JR; Klimberg S; Wei JY; Bai JP; Li J; Lathrop JT; Beger RD; Todorova VK
Exp Biol Med (Maywood); 2018 Feb; 243(3):248-255. PubMed ID: 29224368
[TBL] [Abstract][Full Text] [Related]
12. Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto-GBG 84 Trial.
Rüger AM; Schneeweiss A; Seiler S; Tesch H; van Mackelenbergh M; Marmé F; Lübbe K; Sinn B; Karn T; Stickeler E; Müller V; Schem C; Denkert C; Fasching PA; Nekljudova V; Garfias-Macedo T; Hasenfuß G; Haverkamp W; Loibl S; von Haehling S
J Am Heart Assoc; 2020 Dec; 9(23):e018143. PubMed ID: 33191846
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Impact of Global Longitudinal Strain and NT-proBNP on Early Development of Cardiotoxicity in Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy.
Muckiene G; Vaitiekus D; Zaliaduonyte D; Zabiela V; Verseckaite-Costa R; Vaiciuliene D; Juozaityte E; Jurkevicius R
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241185
[No Abstract] [Full Text] [Related]
14. Protective effects of Panax ginseng against doxorubicin-induced cardiac toxicity in patients with non-metastatic breast cancer: A randomized, double-blind, placebo-controlled clinical trial.
Hamidian M; Foroughinia F; Haghighat S; Attar A; Haem E
J Oncol Pharm Pract; 2023 Sep; 29(6):1306-1316. PubMed ID: 35975564
[TBL] [Abstract][Full Text] [Related]
15. [Metformin mitigates doxorubicin-induced cardiotoxicity
Wei J; Yang Q; Lin L; Zhu C; Wei J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1682-1688. PubMed ID: 37933643
[TBL] [Abstract][Full Text] [Related]
16. Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial.
Lexis CP; van der Horst IC; Lipsic E; Wieringa WG; de Boer RA; van den Heuvel AF; van der Werf HW; Schurer RA; Pundziute G; Tan ES; Nieuwland W; Willemsen HM; Dorhout B; Molmans BH; van der Horst-Schrivers AN; Wolffenbuttel BH; ter Horst GJ; van Rossum AC; Tijssen JG; Hillege HL; de Smet BJ; van der Harst P; van Veldhuisen DJ;
JAMA; 2014 Apr; 311(15):1526-35. PubMed ID: 24687169
[TBL] [Abstract][Full Text] [Related]
17. Assessing the cardiotoxicity of Epirubicin-based chemotherapy in patients with breast cancer using high-sensitivity cardiac troponin T, N-terminal pro b-type natriuretic peptide and soluble suppression of tumorigenicity-2.
Isemede DA; Sharma A; Bailey J
Ann Clin Biochem; 2022 Nov; 59(6):410-419. PubMed ID: 36154484
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic-pharmacodynamic modelling of acute N-terminal pro B-type natriuretic peptide after doxorubicin infusion in breast cancer.
Liang S; Brundage RC; Jacobson PA; Blaes A; Kirstein MN
Br J Clin Pharmacol; 2016 Sep; 82(3):773-83. PubMed ID: 27128712
[TBL] [Abstract][Full Text] [Related]
19. Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer.
Liu Z; Liu M; Zhong X; Qin Y; Liang T; Luo T; Yan X; Tang Z; Wang X; Liang S; Li Q; Ruan X; He W; Huang H
Cancer Med; 2023 Jun; 12(12):13374-13387. PubMed ID: 37183826
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of N-terminal pro-B-type natriuretic peptide (NT-ProBNP) as a marker for cardiotoxicity and comparison with echocardiography in paediatric carbon monoxide poisoning.
Turan C; Dogan E; Yurtseven A; Saz EU
Cardiol Young; 2020 Aug; 30(8):1103-1108. PubMed ID: 32571446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
